THE ASMARLEY CHARITABLE TRUST
To assist cancer, heart and general medical research at Royal Brompton Hospital.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds increased to £2,539,603, supported by investment performance despite a decrease in dividend income. The charity does not employ staff and relies on professional investment management to generate income for its charitable grants. The trustees confirm that systems are in place to manage strategic and operational risks.
What the accounts disclose
Trustees
- CHRISTOPHER WILLIAM GOLDSMITHchair
- DAVID GOLDSMITH
- Graham Boughton
- NICHOLAS JAMES GINGER
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £49k | £23k |
| 31/07/2024 | £75k | £20k |
| 31/07/2023 | £75k | £22k |
| 31/07/2022 | £81k | £22k |
| 31/07/2021 | £66k | £21k |
Common questions
Is THE ASMARLEY CHARITABLE TRUST financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds increased to £2,539,603, supported by investment performance despite a decrease in dividend income. The charity does not employ staff and relies on professional investment management to generate income for its charitable grants. The trustees confirm that systems are in place to manage strategic and operational risks. Its FY2025 accounts were independently examined.